We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
When faced with drug shortages or supply chain issues affecting a branded drug product, generic drug manufacturers need to move quickly to help ensure that needed therapies reach the market safely and efficiently. Access to high-quality packaging and delivery components can make a huge difference in ensuring patients receive life-saving medications on schedule.
At West, we work by the side of our generic drug partners to ensure that they have access to components that not only meet the increasing demand for better quality packaging and delivery for generic drug products, but also provide the efficiencies they need to make the move to market fast.
Speed to market is also important for generic customers who may hold a number of Abbreviated New Drug Applications (ANDAs ) and need to move quickly to produce different products in their portfolio, which can be driven by market conditions such as drug shortages where there is a need to respond immediately.
Our AccelTRA® component program provides a robust, efficient platform of components that are compatible with a broad variety of generics molecules and chemicals. This program offers customers the possibility of building a platform of delivery options and packaging for a variety of molecules with a single supply platform.
In addition, West has built a global supply chain network to provide made-to-stock AccelTRA components with extremely fast sampling and delivery lead times. Samples are available with a one-week lead time, and commercial quantities within six weeks.
At West, we’re by your side with excellent technical service that helps customers work through issues and make the move to market fast. We bring the service solutions – including laboratory services, contract manufacturing, and regulatory support for a growing number of proprietary delivery devices – so that customers that need to move fast have the services available to help.Click the links for more information about our AccelTRA program, or our Integrated Solutions (link) program.
AccelTRA® is a registered trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Westpharma.com has been upgraded! The new, mobile-friendly site offers easier navigation, intuitive design and enhanced searchability. The new site is mobile-friendly, and can be easily viewed and navigated from phones and tablets.
In October 2017, PDA (Parenteral Drug Association), held a joint workshop with PQRI (Product Quality Research Institute) entitled: <strong>Container Closure, Devices and Delivery Systems: Compatibility and Material Safety Workshop. </strong><br /><br />
Working at West means having an opportunity to work by the side of our global team members and the communities in which we operate, as well as our patients and customers – which all help contribute to a healthier world.
The current global market of prefilled syringes is comprised of over two billion units per year and growing. Many chronic diseases, such as multiple sclerosis and rheumatoid arthritis, require home-based administration of injectable therapies.
Join West’s Graham Reynolds as he presents the keynote at Pharmapack North America. Graham will present, “<em><strong>Understanding the regulations and safety concerns surrounding injectables to overcome inherent design challenges” </strong>on </em>Wednesday, May 23, 2012 at 1:50 pm. The conference will be held at the Pennsylvania Convention Center, Philadelphia, PA on May 22-23.